Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Net Income (2022 - 2025)

Gossamer Bio's Net Income history spans 4 years, with the latest figure at -$47.2 million for Q4 2025.

  • For Q4 2025, Net Income fell 43.01% year-over-year to -$47.2 million; the TTM value through Dec 2025 reached -$173.0 million, down 191.67%, while the annual FY2025 figure was -$170.4 million, 201.39% down from the prior year.
  • Net Income reached -$47.2 million in Q4 2025 per GOSS's latest filing, up from -$48.2 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $49.3 million in Q2 2024 to a low of -$59.0 million in Q3 2022.
  • Average Net Income over 4 years is -$40.3 million, with a median of -$46.0 million recorded in 2024.
  • Peak YoY movement for Net Income: surged 215.93% in 2024, then plummeted 177.68% in 2025.
  • A 4-year view of Net Income shows it stood at -$57.2 million in 2022, then rose by 15.85% to -$48.1 million in 2023, then skyrocketed by 31.39% to -$33.0 million in 2024, then crashed by 43.01% to -$47.2 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Net Income are -$47.2 million (Q4 2025), -$48.2 million (Q3 2025), and -$38.3 million (Q2 2025).